In the present study, patients with stable CAD on single antiplatelet treatment with clopidogrel had significantly reduced response when being carriers of the CYP 2C19*2 variant allele as compared to wild-type patients, when evaluated with the VASP method, and even more pronounced with the VerifyNow P2Y12 method. The gene discussed is VASP; the disease is coronary artery disorder.